Aarti Pharmalabs launches advanced R&D laboratory in Nerul, Navi Mumbai
Aarti Pharmalabs Limited (APL) has recently inaugurated its new Research and Development (R&D) Laboratory in Nerul, Navi Mumbai marking a significant milestone in its commitment to advancing pharmaceutical research. The cutting-edge facility is now fully operational and poised to enhance the company’s Contract Development & Manufacturing (CDMO) business.
Advanced Technology and Safety Features of the New Facility
The laboratory is equipped with cutting-edge technology and instruments, including a dedicated section for flow chemistry. Emphasizing safety and sustainability, the facility includes a Process Safety Laboratory with advanced technology for studying both intended and unintended reactions, ensuring high safety standards. The laboratory’s design features modern fume hoods, an advanced HVAC system, and a Scrubbing system, prioritizing the safety of scientists and a secure working environment.
Embracing Environmental Sustainability in Pharma Research
In line with Aarti Pharmalabs’ commitment to environmental consciousness, the new laboratory operates entirely paperless, utilizing e-books and the latest software for conducting experiments. This eco-friendly approach signifies a significant step towards sustainability in the pharmaceutical sector.
Future-Ready Design for Expanding Research Initiatives
Designed with ample space for future expansion, the laboratory is well-prepared to accommodate the growing demands of upcoming research and development projects. This foresight ensures that Aarti Pharmalabs remains at the forefront of pharmaceutical innovation and exploration.
Inauguration Event Highlights Unified Commitment
The inauguration event was attended by Aarti Pharmalabs’ Chairman Emeritus, Chairman, Directors, Senior Management team, and dedicated team members. This collective endeavor highlights a unified commitment to driving the pharmaceutical sector into a new era of innovation and exploration.
Discover more from Business-News-Today.com
Subscribe to get the latest posts sent to your email.